Triparna Sen (Sen-Lab), Professor at The Ohio State University, shared Ohio State Medical Oncology’s post on X, adding:
“Thrilled to share our latest work in The Oncologist: ‘Antibody–Drug Conjugates in Small-Cell Lung Cancer: Present-Day Status and Promises’.
Despite early response signals, challenges such as resistance, antigen heterogeneity, and toxicity persist, and innovation in payloads, linkers, and trial design will be key to progress.”
Quoting Ohio State Medical Oncology’s post:
“New publication from Triparna Sen and colleagues in The Oncologist.”
Title: Antibody drugs conjugates in small-cell lung cancer: present-day status and promises
Authors: Arjun Syal, May-Lucie Meyer, Kenneth Angelino, Noah Osei, Jorge E Gomez, Fred R Hirsch, Triparna Sen
Read the Full Article on The Oncologist
More posts featuring Triparna Sen.